Evaluate the Safety and Efficacy of Oral Treprostinil in Subjects with Pulmonary Hypertension in Heart FAilure with Preserved Ejection Fraction (HFpEF)
Clinical Trial Grant
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
August 17, 2017
End Date
November 14, 2020
Administered By
Medicine, Pulmonary, Allergy, and Critical Care Medicine
Awarded By
United Therapeutics Corporation
Start Date
August 17, 2017
End Date
November 14, 2020